Neurotropism and Therapeutic Targeting of Brain Metastases in Small Cell Lung Cancer.

Small cell lung cancer exhibits a high 80% rate of brain metastases driven by neurotropic mechanisms and resistance to current therapies.

• Why it matters: Understanding the biology of brain metastases in SCLC is crucial because they cause significant morbidity and are difficult to treat due to limited drug penetration and resistance.
• What they did: The study reviews recent insights into SCLC brain metastasis mechanisms, including neuronal mimicry and cell crosstalk, and evaluates emerging therapies targeting DLL3 and B7H3 in preclinical and clinical settings.
• The result: Advances in understanding SCLC brain metastasis biology have led to promising targeted therapies, but overcoming treatment resistance and improving brain drug delivery remain critical challenges for future progress.